CancerX shared a post on LinkedIn:
“Kick off your JPM 2026 week with CancerX!
Join us for CancerX’s first-ever program at JPM 2026, where the focus shifts from promise to practice in cancer innovation.
On Sunday, January 11 (2–5 PM PT) at The City Club of San Francisco, our CancerX program at JPM will explore:
- How innovation at the edge, where science, technology, and care delivery meet, is shaping the future of oncology
- What it will take to make clinical trials smarter, faster, and accessible as a standard part of care
- Why breakthrough therapies and digital solutions struggle to reach patients and how to close gaps across adoption, logistics, and scale
- The role of wearables and non-AI technologies across detection, monitoring, and survivorship
- How code, capital, and cleaner futures can help us rethink cancer prevention and intervene earlier
This conversation is powered by the CancerX community and grounded in real-world execution, patient impact, and cross-stakeholder collaboration.
Join us and be part of the conversation.”
More posts from CancerX.